“oncology” Archives

in
Entry Author Date Location
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
Pet Dogs Help Biotech Startups Find New Weapons to Fight Cancer 07/25/12 San Diego
ImmunoGen Emerges from Genentech’s Shadow With Novel Cancer Drugs 07/12/12 Boston
Bristol-Myers Wrangles Top Academics to Study Immunity in Cancer 06/07/12 New York
FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed 06/06/12 New York
Bayer Oncology Dubs ASCO “Turning Point” for Cancer Efforts 06/06/12 New York
Merck Oncology Chief Heads to ASCO With High Hopes for New Drugs 05/31/12 New York
Genentech, Roche Find New Balance Three Years Post-Merger 05/29/12 San Francisco
The 2012 New York ASCO Checklist 05/24/12 New York
NY’s Cancer Research Institute Looks to Boost Cancer Immunotherapy 05/09/12 New York
Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs 05/01/12 Boston
Ariad and Merck Face Tough FDA Review of Sarcoma Pill 03/20/12 Boston
Molecular Health Sets up in NYC With Personalized Med Tools 03/07/12 New York
FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis 01/30/12 Boston
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
Foundation Medicine and Sanofi Form Cancer Discovery Pact 01/10/12 Boston
Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011 12/27/11 New York
Metamark Inks Potential $365M Deal with J&J For Cancer Marker Discovery 12/19/11 Boston
Coronado Biosciences Debuts on Nasdaq, Moves Two Lead Drugs Forward 12/19/11 Boston
Cerulean Pharma Adds $15M to Further Nano-Drug Platform 12/15/11 Boston
Avila Shows Progress in Covalent Cancer Drugs at Prominent ASH Confab 12/12/11 Boston
Aileron CEO Hails Expanded Roche Deal as a Validation of Stapled-Peptide Drug Technology 11/17/11 Boston
Agios Nabs $78M From Partner Celgene, Existing VCs, and Public Funds 11/17/11 Boston
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage 10/11/11 Boston
Xconomist of the Week: Pfizer’s Barbara Dalton to Speak at Our NY Life Sciences 2031 Forum 09/29/11 New York
RXi Splits Into Two Public Companies After Adding Cancer Vaccine to Pipeline 09/26/11 Boston
Ariad Brings Third Cancer Drug Into Human Trials 09/22/11 Boston
J&J Honors Genentech Scientist, Holds Meeting on Future of Anti-Angiogenesis Drugs 09/15/11 New York
Aura Biosciences Raises $4.5M to Advance Nano-Drug Weapon Against Cancer 09/08/11 Boston
Page 2 of 3 « previous page · next page »